These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 32252475)
1. Human Embryonic Stem Cell-Derived Wilson's Disease Model for Screening Drug Efficacy. Kim D; Kim SB; Ryu JL; Hong H; Chang JH; Yoo TJ; Jin X; Park HJ; Han C; Lee BH; Choi JH; Yoo HW; Kim JH; Woo DH Cells; 2020 Apr; 9(4):. PubMed ID: 32252475 [TBL] [Abstract][Full Text] [Related]
2. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease. Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514 [TBL] [Abstract][Full Text] [Related]
3. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Zhang S; Chen S; Li W; Guo X; Zhao P; Xu J; Chen Y; Pan Q; Liu X; Zychlinski D; Lu H; Tortorella MD; Schambach A; Wang Y; Pei D; Esteban MA Hum Mol Genet; 2011 Aug; 20(16):3176-87. PubMed ID: 21593220 [TBL] [Abstract][Full Text] [Related]
4. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models. Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740 [TBL] [Abstract][Full Text] [Related]
5. Aberrant copper metabolism and hepatic inflammation cause neurological manifestations in a mouse model of Wilson's disease. Dong J; Xiang G; Xia X; Xu L; Wen P; Xu C; Xu Y; Su Y; Song Y; Tong H; Zhu Q; Han Y; Han Y; Cheng N; Wang H; Zhou H J Neuroinflammation; 2024 Sep; 21(1):235. PubMed ID: 39334421 [TBL] [Abstract][Full Text] [Related]
6. Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi003-A) from a Wilson's disease patient harboring a homozygous R778L mutation in ATP7B gene. Zhang J; Wei L; Chen D; Feng L; Wu C; Wang R; Li X Stem Cell Res; 2019 Dec; 41():101664. PubMed ID: 31783295 [TBL] [Abstract][Full Text] [Related]
7. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
8. Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes. Song D; Takahashi G; Zheng YW; Matsuo-Takasaki M; Li J; Takami M; An Y; Hemmi Y; Miharada N; Fujioka T; Noguchi M; Nakajima T; Saito MK; Nakamura Y; Oda T; Miyaoka Y; Hayashi Y Hum Mol Genet; 2022 Oct; 31(21):3652-3671. PubMed ID: 35388883 [TBL] [Abstract][Full Text] [Related]
9. Analysis and application of ATP7B gene mutations in 35 patients with hepatolenticular degeneration. Zong YN; Kong XD Genet Mol Res; 2015 Dec; 14(4):18764-70. PubMed ID: 26782526 [TBL] [Abstract][Full Text] [Related]
10. Neurologic Wilson's disease. Lorincz MT Ann N Y Acad Sci; 2010 Jan; 1184():173-87. PubMed ID: 20146697 [TBL] [Abstract][Full Text] [Related]
11. [Genotype and phenotype correlation in Chinese patients with Wilson's Disease]. Liu XQ; Zhang YF; Liu TT; Gu XF; Hsiao KJ; Bao KR; Yu LH Zhonghua Er Ke Za Zhi; 2003 Jan; 41(1):35-8. PubMed ID: 14761325 [TBL] [Abstract][Full Text] [Related]
13. In Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699 [TBL] [Abstract][Full Text] [Related]
14. Generation of ZJUi003-A, an induced pluripotent stem cell line from a Wilson's disease patient carrying a c.180_181del mutation in ATP7B gene. Wang J; Su J; Gong T; Li T; Shen J; Wang H; Xie H; Zhou L; Zheng S; Liang P Stem Cell Res; 2020 Jul; 46():101873. PubMed ID: 32534167 [TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic characterization of a large cohort of patients with Wilson's disease in China. Zhang S; Yang W; Li X; Pei P; Dong T; Yang Y; Zhang J Transl Neurodegener; 2022 Feb; 11(1):13. PubMed ID: 35220961 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease. Wooton-Kee CR Pharmacol Ther; 2023 Nov; 251():108529. PubMed ID: 37741465 [TBL] [Abstract][Full Text] [Related]
17. Establishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cells. Yi F; Qu J; Li M; Suzuki K; Kim NY; Liu GH; Belmonte JC Protein Cell; 2012 Nov; 3(11):855-63. PubMed ID: 22806248 [TBL] [Abstract][Full Text] [Related]
18. Copper-Induced Epigenetic Changes Shape the Clinical Phenotype in Wilson's Disease. Fanni D; Gerosa C; Nurchi VM; Cappai R; Mureddu M; Eyken PV; Saba L; Manchia M; Faa G Curr Med Chem; 2021; 28(14):2707-2716. PubMed ID: 32744959 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of Liver Fibrosis by N2 Neutrophils in Wilson's Disease. Mi X; Song Y; Deng C; Yan J; Li Z; Li Y; Zheng J; Yang W; Gong L; Shi J Cell Mol Gastroenterol Hepatol; 2023; 16(5):657-684. PubMed ID: 37406734 [TBL] [Abstract][Full Text] [Related]
20. [Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in Korean patients with Wilson's disease]. Bae SH; Kim JW; Seo JK Korean J Hepatol; 2009 Sep; 15(3):309-19. PubMed ID: 19783880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]